Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'angiotensin receptor antagonist' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 243 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fagard, R; Lijnen, P; Pardaens, K; Thijs, L; Vinck, W
      A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

      JOURNAL OF HUMAN HYPERTENSION
    2. Ohnishi, K; Kohno, M; Yukiiri, K; Masugata, H; Wada, Y; Takagi, Y; Ohmori, K
      Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    3. Lopau, K; Hefner, L; Bender, G; Heidbreder, E; Wanner, C
      Haemodynamic effects of valsartan in acute renal ischaemia/reperfusion injury

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    4. Kawabata, H; Ryomoto, T; Ishikawa, K
      Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type I receptor antagonist is not abolished by nitric oxide synthaseinhibitor in ischemia-reperfused rabbit hearts

      Hypertension research
    5. Sasamura, H; Shimizu-Hirota, R; Nakaya, H; Saruta, T
      Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats

      Hypertension research
    6. Hara, K; Kobayashi, N; Nakano, S; Mori, Y; Tsubokou, Y; Matsuoka, H
      Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats

      Hypertension research
    7. Blezer, ELA; Nicolay, K; Koomans, HA; Joles, JA
      Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats

      AMERICAN JOURNAL OF HYPERTENSION
    8. Fishman, S; Rapoport, MJ; Weissgarten, J; Zaidenstein, R; Dishi, V; Hartzeanu, I; Golik, A
      The effect of losartan on insulin resistance and beta cell function in chronic hemodialysis patients

      RENAL FAILURE
    9. Maillard, JO; Descombes, E; Fellay, G; Regamey, C
      Repeated transient anuria following losartan administration in a patient with a solitary kidney

      RENAL FAILURE
    10. Mancia, G
      Clinical differences among angiotensin II receptor antagonists

      BLOOD PRESSURE
    11. Unger, T
      Inhibiting renin-angiotensin in the brain: the possible therapeutic implications

      BLOOD PRESSURE
    12. Berry, C; Touyz, R; Dominiczak, AF; Webb, RC; Johns, DG
      Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    13. Taal, MW; Chertow, GM; Rennke, HG; Gurnani, A; Jiang, T; Shahsafaei, A; Troy, JL; Brenner, BM; Mackenzie, HS
      Mechanisms underlying renoprotection during renin-angiotensin system blockade

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    14. Hanefeld, M; Abletshauser, C
      Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    15. Lewis, EJ; Hunsicker, LG; Rodby, RA
      A clinical trial in type 2 diabetic nephropathy

      AMERICAN JOURNAL OF KIDNEY DISEASES
    16. Waeber, B; Aschwanden, R; Sadecky, L; Ferber, P
      Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

      JOURNAL OF HYPERTENSION
    17. Coats, AJS
      Angiotensin Receptor Blockers - finally the evidence is coming in: IDNT and RENAAL

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    18. Hiura, N; Wakatsuki, T; Yamamoto, T; Nishikado, A; Oki, T; Ito, S
      Effects of angiotensin II type 1 receptor antagonist (candesartan) in preventing fatal ventricular arrhythmias in dogs during acute myocardial ischemia and reperfusion

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    19. Berlowitz, MS; Latif, F; Hankins, SR; Ennezat, PV; Moskowitz, R; Tandon, S; Colombo, PC; Le Jemtel, TH
      Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    20. Basset, A; Blanc, J; Messas, F; Hagege, Y; Elghozi, JL
      Renin-angiotensin system contribution to cardiac hypertrophy in experimental hyperthyroidism: An echocardiographic study

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    21. Cao, ZM; Bonnet, F; Davis, B; Allen, TJ; Cooper, ME
      Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats

      CLINICAL SCIENCE
    22. Kawabata, H; Ryomoto, T; Ishikawa, K
      Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    23. Morizawa, Y; Okazoe, T; Wang, SZ; Sasaki, J; Ebisu, H; Nishikawa, M; Shinyama, H
      A novel trifluoromethanesulfonamidophenyl-substituted quinoline derivative, GA 0113: synthesis and pharmacological profiles

      JOURNAL OF FLUORINE CHEMISTRY
    24. Kobayashi, N; Mori, Y; Nakano, S; Tsubokou, Y; Kobayashi, T; Shirataki, H; Matsuoka, H
      TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats

      ATHEROSCLEROSIS
    25. Tokioka-Akagi, T; Fujimori, A; Shibasaki, M; Inagaki, O; Yanagisawa, I
      Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload

      JAPANESE JOURNAL OF PHARMACOLOGY
    26. Noda, M; Matsuo, C; Nagano-Tsuge, H; Ohta, M; Sekiguchi, M; Shibouta, Y; Naka, T; Imura, Y
      Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats)

      JAPANESE JOURNAL OF PHARMACOLOGY
    27. Fujimoto, Y; Sasaki, T; Tsuchida, A; Chayama, K
      Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist

      FEBS LETTERS
    28. Breno, MC; Porto, CS; Picarelli, ZP
      Angiotensin receptor in the heart of Bothrops jararaca snake

      EUROPEAN JOURNAL OF PHARMACOLOGY
    29. Bonnet, F; Cooper, ME; Kawachi, H; Allen, TJ; Boner, G; Cao, Z
      Irbesartan normalises the deficiency in glomerular nephrin expression in amodel of diabetes and hypertension

      DIABETOLOGIA
    30. Katovich, MJ; Pachori, A
      Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin

      DIABETES OBESITY & METABOLISM
    31. Gremmler, B; Kunert, M; Schleiting, H; Ulbricht, LJ
      Improvement of cardiac output in patients with severe heart failure by useof ACE-inhibitors combined with the AT1-antagonist eprosartan

      EUROPEAN JOURNAL OF HEART FAILURE
    32. Yamabe, H; Osawa, H; Kaizuka, M; Tamura, N; Tsunoda, S; Shirato, K; Tateyama, F; Okumura, K
      Angiotensin II further enhances type IV collagen production stimulated by platelet-derived growth factor and fibroblast growth factor-2 in cultured human mesangial cells

      NEPHROLOGY
    33. Mancia, G; Grassi, G
      The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil

      JOURNAL OF HUMAN HYPERTENSION
    34. Unger, T; Azizi, M; Belz, GG
      Blocking the tissue renin-angiotensin system: the future cornerstone of therapy

      JOURNAL OF HUMAN HYPERTENSION
    35. Mallion, JM; Baguet, JP
      Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data

      JOURNAL OF HUMAN HYPERTENSION
    36. Hernandez-Hernandez, R; Velasco, M; Armas-Hernandez, MJ; Armas-Padilla, MC
      Angiotensin II receptor antagonists in arterial hypertension

      JOURNAL OF HUMAN HYPERTENSION
    37. Paterna, S; Parrinello, G; Scaglione, R; Costa, R; Bova, A; Palumbo, VA; Pinto, A; Amato, P; Licata, G
      Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients

      CARDIOVASCULAR DRUGS AND THERAPY
    38. Viigimaa, M; Allikmets, K; Parik, T; Skards, J; Franken, A; Hass, G
      Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: Comparison with enalapril

      CARDIOVASCULAR DRUGS AND THERAPY
    39. Tokioka, T; Shibasaki, M; Fujimori, A; Matsuda-Satoh, Y; Uchida, W; Inagaki, O; Yanagisawa, I
      Effects of YM358, an angiotensin II type 1 (AT(1)) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    40. Kohno, M; Ohmori, K; Nozaki, S; Mizushige, K; Yasunari, K; Kano, H; Minami, M; Yoshikawa, J
      Effects of valsartan on angiotensin II-induced migration of human coronaryartery smooth muscle cells

      Hypertension research
    41. Zhou, A; Yu, L; Li, JZ; Zhang, JF; Wang, HY
      Renal protective effects of blocking the intrarenal renin-angiotensin system: Angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor

      Hypertension research
    42. Higashiura, KS; Ura, N; Takada, T; Li, Y; Torii, T; Togashi, N; Takada, M; Takizawa, H; Shimamoto, K
      The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats

      AMERICAN JOURNAL OF HYPERTENSION
    43. Yamakawa, H; Imamura, T; Matsuo, T; Onitsuka, H; Tsumori, Y; Kato, J; Kitamura, K; Koiwaya, Y; Eto, T
      Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    44. Weisinger, RS; Burns, P; Colvill, LM; Davern, P; Giles, ME; Oldfield, BJ; McKinley, MJ
      Fos immunoreactivity in the lamina terminalis of adrenalectomized rats andeffects of angiotension II type 1 receptor blockade or deoxycorticosterone

      NEUROSCIENCE
    45. Gosselin, MJ; Leclerc, PC; Auger-Messier, M; Guillemette, G; Escher, E; Leduc, R
      Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    46. Katoh, M; Egashira, K; Mitsui, T; Takeshita, A; Narita, H
      Differential effects of imidapril and candesartan cilexetil on plasminogenactivator inhibitor-1 expression induced by prolonged inhibition of nitricoxide synthesis in rat hearts

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    47. Higashi, T; Kobayashi, N; Hara, K; Shirataki, H; Matsuoka, H
      Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in goldblatt hypertensive rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    48. Woo, KT; Lau, YK; Wong, KS; Chiang, GSC
      ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis

      KIDNEY INTERNATIONAL
    49. Kawabata, H; Ryomoto, T; Ishikawa, K
      Effect of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist on metabolism and contraction in ischemia-reperfused rabbit heart

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    50. Baba, T; Kanda, T; Kobayashi, I
      Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice

      LIFE SCIENCES
    51. Khalil, A; Tullus, K; Bakhiet, M; Burman, LG; Jaremko, G; Brauner, A
      Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis

      JOURNAL OF UROLOGY
    52. Dinnebier, RE; Sieger, P; Nar, H; Shankland, K; David, WIF
      Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction

      JOURNAL OF PHARMACEUTICAL SCIENCES
    53. Hoshida, S; Yamashita, N; Kuzuya, T; Hori, M
      Differential effects of long-term renin-angiotensin system blockade on limitation of infarct size in cholesterol-fed rabbits

      ATHEROSCLEROSIS
    54. Girgrah, N; Liu, P; Collier, J; Blendis, L; Wong, F
      Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis

      GUT
    55. Verhagen, AMG; Hohbach, J; Joles, JA; Braam, B; Boer, P; Koomans, HA; Grone, HJ
      Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition

      EUROPEAN JOURNAL OF PHARMACOLOGY
    56. Yoshimura, M; Yasue, H
      Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure

      CARDIOLOGY
    57. Stenhoff, H; Lagerstrom, PO; Andersen, C
      Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection

      JOURNAL OF CHROMATOGRAPHY B
    58. Littlejohn, T; Saini, R; Kassler-Taub, K; Crysant, SG; Marbury, T
      Long-term safety and antihypertensive efficacy of irbesartan: Pooled results of five open-label studies

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    59. Howe, P; Phillips, P; Saini, R; Kassler-Taub, K
      The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    60. Elliott, WJ
      Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients

      JOURNAL OF HUMAN HYPERTENSION
    61. Pool, JL; Glazer, R; Chiang, YT; Gatlin, M
      Dose-response efficacy of valsartan, a new angiotensin II receptor blocker

      JOURNAL OF HUMAN HYPERTENSION
    62. Raskin, P; Guthrie, R; Flack, JM; Reeves, RA; Saini, R
      The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide

      JOURNAL OF HUMAN HYPERTENSION
    63. Sever, PS
      Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists

      JOURNAL OF HUMAN HYPERTENSION
    64. Taal, MW; Brenner, BM
      ACE-I vs angiotensin II receptor antagonists: prevention of renal injury in chronic rat models

      JOURNAL OF HUMAN HYPERTENSION
    65. Higashiura, K; Ura, N; Miyazaki, Y; Shimamoto, K
      Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension

      JOURNAL OF HUMAN HYPERTENSION
    66. Nawarskas, JJ; Townsend, RR; Cirigliano, MD; Spinler, SA
      Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan

      AMERICAN JOURNAL OF HYPERTENSION
    67. Obayashi, M; Yano, M; Kohno, M; Kobayashi, S; Yamamoto, T; Ohkusa, T; Konishi, M; Matsuzaki, M
      Effect of angiotensin II receptor antagonism on vascular hypertrophy and aortic impedance in abdominal aortic-banded rat

      AMERICAN JOURNAL OF HYPERTENSION
    68. Erdem, Y; Usalan, C; Haznedaroglu, IC; Altun, B; Arici, M; Yasavul, U; Turgan, C; Caglar, S
      Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    69. Uehara, Y; Hirawa, N; Kawabata, Y; Numabe, A; Gomi, T; Ikeda, T; Omata, M
      Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus

      AMERICAN JOURNAL OF HYPERTENSION
    70. Hope, S; Brecher, P; Chobanian, AV
      Comparison of the effects of AT(1) receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis

      AMERICAN JOURNAL OF HYPERTENSION
    71. Sebekova, K; Schinzel, R; Munch, G; Krivosikova, Z; Dzurik, R; Heidland, A
      Advanced glycation end-product levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan

      MINERAL AND ELECTROLYTE METABOLISM
    72. Su, J; Barbe, F; Houel, R; Guyene, TT; Crozatier, B; Hittinger, L
      Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure - Differential acute effects according to the renin-angiotensin system activation

      BASIC RESEARCH IN CARDIOLOGY
    73. Birkenhager, WH; de Leeuw, PW
      Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension

      JOURNAL OF HYPERTENSION
    74. De Paolis, P; Porcellini, A; Gigante, B; Giliberti, R; Lombardi, A; Savoia, C; Rubattu, S; Volpe, M
      Modulation of the AT(2) subtype receptor gene activation and expression bythe AT(1) receptor in endothelial cells

      JOURNAL OF HYPERTENSION
    75. Blanc, J; Ponchon, P; Laude, D; Elghozi, JL; Jover, B
      Blood pressure variability in established L-NAME hypertension in rats

      JOURNAL OF HYPERTENSION
    76. Hedner, T; Himmelmann, A
      The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension

      JOURNAL OF HYPERTENSION
    77. Blais, C; Leclair, P; Molinaro, G; Adam, A
      Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations in the carrageenan-induced paw edema model inthe rat

      PEPTIDES
    78. de Gasparo, M; Siragy, HM
      The AT(2) receptor: fact, fancy and fantasy

      REGULATORY PEPTIDES
    79. Kurosawa, Y; Minami, K; Hashimoto, Y; Narita, H
      Functional and binding studies of insurmountable antagonism of 606A, a novel AT(1)-receptor antagonist in rabbit tissues

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    80. Gradman, AH; Gray, J; Maggiacomo, F; Punzi, H; White, WB
      Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

      CLINICAL THERAPEUTICS
    81. Hashida, H; Hamada, M; Hiwada, K
      Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist

      CLINICAL SCIENCE
    82. Shahinfar, S; Simpson, RL; Carides, AD; Thiyagarajan, B; Nakagawa, Y; Parks, JH; Coe, FL
      Safely of losartan in hypertensive patients with thiazide-induced hyperuricemia

      KIDNEY INTERNATIONAL
    83. Noda, M; Matsuo, T; Fukuda, R; Ohta, M; Nagano, H; Shibouta, Y; Naka, T; Nishikawa, K; Imura, Y
      Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure

      KIDNEY INTERNATIONAL
    84. Kawabata, H; Ryomoto, T; Ishikawa, K
      Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    85. Hashimoto, Y; Ohashi, R; Minami, K; Narita, H
      Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension

      JAPANESE JOURNAL OF PHARMACOLOGY
    86. Xia, QG; Chung, O; Spitznagel, H; Sandmann, S; Illner, S; Rossius, B; Jahnichen, G; Reinecke, A; Gohlke, P; Unger, T
      Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction

      EUROPEAN JOURNAL OF PHARMACOLOGY
    87. Chansel, D; Vandermeersch, S; Llorens-Cortes, C; Ardaillou, R
      Effects of angiotensin II and antagonists on AT(1) receptor expression in mesangial cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    88. Nagamatsu, T; Hayashi, K; Oka, T; Suzuki, Y
      Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis

      EUROPEAN JOURNAL OF PHARMACOLOGY
    89. Karakoc, A; Arinsoy, T; Gencosmanoglu, O; Sindel, S
      Effects of an angiotensin II receptor antagonist on urinary albumin excretion, left ventricular mass, and systolic and diastolic blood pressures in essential hypertension

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    90. Inada, Y; Murakami, M; Kaido, K; Nakao, K
      Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    91. ZOJA C; LIU XH; ABBATE M; CORNA D; SCHIFFRIN EL; REMUZZI G; BENIGNI A
      ANGIOTENSIN-II BLOCKADE LIMITS TUBULAR PROTEIN OVERREABSORPTION AND THE CONSEQUENT UP-REGULATION OF ENDOTHELIN-1 GENE IN EXPERIMENTAL MEMBRANOUS NEPHROPATHY

      Experimental nephrology
    92. TEDESCO MA; RATTI G; AQUINO D; LIMONGELLI G; DISALVO G; MENNELLA S; GALZERANO D; IARUSSI D; IACONO A
      EFFECTS OF LOSARTAN ON HYPERTENSION AND LEFT-VENTRICULAR MASS - A LONG-TERM STUDY

      Journal of human hypertension
    93. CIFKOVA R; PELESKA J; HRADEC J; ROSOLOVA H; PINTEROVA E; ZEMAN K; ODDOUSTOCK P; THIRLWELL J; BOTTERI F
      VALSARTAN AND ATENOLOL IN PATIENTS WITH SEVERE ESSENTIAL-HYPERTENSION

      Journal of human hypertension
    94. MIMRAN A; RUILOPE L; KERWIN L; NYS M; OWENS D; KASSLERTAUB K; OSBAKKEN M
      A RANDOMIZED, DOUBLE-BLIND COMPARISON OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IRBESARTAN, WITH THE FULL DOSE RANGE OF ENALAPRIL FOR THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION

      Journal of human hypertension
    95. Mitsunami, K; Inoue, S; Maeda, K; Endoh, S; Takahashi, M; Okada, M; Sugihara, H; Kinoshita, M
      Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT(1)) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension

      CARDIOVASCULAR DRUGS AND THERAPY
    96. KINOSHITA M; WADA A
      SYMPOSIUM ON MORBIDITY OF BODY-FLUID BALANCE AND ITS TREATMENT - 5 - A FUNCTIONAL-ROLE FOR ENDOGENOUS ATRIAL-NATRIURETIC-PEPTIDE IN THE MAINTENANCE OF BODY-FLUID BALANCE IN HEART-FAILURE

      Internal medicine
    97. SUGIMOTO K; FUJIMURA A; TAKASAKI I; TOKITA Y; IWAMOTO T; TAKIZAWA T; GOTOH E; SHIONOIRI H; ISHII M
      EFFECTS OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE AND DIETARY SALT INTAKE ON LEFT-VENTRICULAR HYPERTROPHY IN DAHL SALT-SENSITIVE RATS

      Hypertension research
    98. KASSLERTAUB K; LITTLEJOHN T; ELLIOTT W; RUDDY T; ADLER E
      COMPARATIVE EFFICACY OF 2 ANGIOTENSIN-II RECEPTOR ANTAGONISTS, IRBESARTAN AND LOSARTAN, IN MILD-TO-MODERATE HYPERTENSION

      American journal of hypertension
    99. LACOURCIERE Y; POOL JL; SVETKEY L; GRADMAN AH; LAROCHELLE P; DECHAMPLAIN J; SMITH WB
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER TRIAL OF 4 DOSES OF TASOSARTAN IN PATIENTS WITH ESSENTIAL-HYPERTENSION

      American journal of hypertension
    100. POOL JL; GUTHRIE RM; LITTLEJOHN TW; RASKIN P; SHEPHARD AMM; WEBER MA; WEIR MR; WILSON TW; WRIGHT J; KASSLERTAUB KB; REEVES RA
      DOSE-RELATED ANTIHYPERTENSIVE EFFECTS OF IRBESARTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION

      American journal of hypertension


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:26:44